Sophisticated Breast Cancer Imaging Close to Reality

TeraView (Cambridge, UK) is currently conducting a series of studies with Cambridge Consultants (Cambridge, UK), imaging both cancerous and healthy breast tissues. With this technology, developed by TeraView, considerable healthcare costs could be saved worldwide by reducing the need for repeated surgical procedures.

TeraView is a company that solely exploits terahertz radiation, one of the last unexplored regions of the electromagnetic spectrum. Terahertz radiation is able to image in three-dimensions (3D), providing spectroscopic data, and can differentiate between healthy and diseased tissue. The potential benefits of the system include improved detection rates of diseased breast tissue during surgery, leading to a decrease in the number of repeat surgeries, and therefore, morbidity.

"Our technology development is at a critical stage, and by performing this research study with Cambridge Consultants, a company with both the technical and commercial knowledge to understand the technology, we hope to see TeraView technology introduced into operating theaters within the next three years,” commented Dr. Don Arnone, CEO of TeraView.

Dr. Gerald Dunstan, senior business consultant at Cambridge Consultants added, "Lessening the need for a second procedure by using terahertz imaging technology in the initial surgery will not only provide considerable health economic benefits, but may also provide improved recovery rates and a reduction in the trauma for the patient at an already trying time. By engaging with surgeons, we can develop, analyze, and recommend a number of strategies to TeraView in order to help them achieve successful market entry for this exciting technology.”




Related Links:
TeraView
Cambridge Consultants